Found 5 matching trials
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas PHASE2 This is a Phase II open-label study to investigate the safety and efficacy ...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme PHASE1 The current design provides a window to analyze the impact of the ACT001+Pe...
Show More Status
Active Not Recruiting
Location
UT MD Anderson Cancer Center, Dept of Neuro-Oncology
Learn More & Join Trial
Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature PHASE2 This trial will study the effectiveness of ACT001 in adult patients whose G...
Show More Location
National Neuroscience Institute
Learn More & Join Trial
A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer EARLY_PHASE1 An exploratory clinical study evaluating the safety and efficacy of ACT#001...
Show More Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma NA This is a single-arm, open-label, exploratory clinical study to evaluate th...
Show More Location
Renji Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial